Santen Pharmaceutical Forecast, price target & analysts
Santen Pharmaceutical Target price 2026 - Analyst rating & recommendation
Santen Pharmaceutical Classifications & Recommendation
Santen Pharmaceutical Price Target
| Target Price | ¥2,371.50 |
| Price | ¥1,738.00 |
| Potential | |
| Number of Estimates | 10 |
| 10 Analysts have issued a price target Santen Pharmaceutical 2027 . The average Santen Pharmaceutical target price is ¥2,371.50. This is higher than the current stock price. The highest price target is , the lowest is . | |
| A rating was issued by 13 analysts: 9 Analysts recommend Santen Pharmaceutical to buy, 4 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
| Analyst Estimates: Analysts believe that the Santen Pharmaceutical stock has an average upside potential 2027 of . Most analysts recommend the Santen Pharmaceutical stock at Purchase. |
Sales and Margin forecast 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Revenue Billion ¥ | ??? | ??? |
| ??? | ??? | |
| EBITDA Margin | ??? | ??? |
| ??? | ??? | |
| Net Margin | ??? | ??? |
| ??? | ??? |
10 Analysts have issued a sales forecast Santen Pharmaceutical 2027 . The average Santen Pharmaceutical sales estimate is
. This is than the revenue of the last 12 months(TTM). The highest sales forecast is , the lowest is .This results in the following potential growth metrics:
10 Analysts have issued an Santen Pharmaceutical EBITDA forecast 2027. The average Santen Pharmaceutical EBITDA estimate is
. This is than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is , the lowest is .This results in the following potential growth metrics and future EBITDA Margins:
10 Santen Pharmaceutical Analysts have issued a net profit forecast 2027. The average Santen Pharmaceutical net profit estimate is
. This is than the net profit for the last 12 months(TTM). The highest net profit forecast is , the lowest is .This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2027, 2028 & 2029
| Mar '26 |
2027 Estimates |
|
|---|---|---|
| Earnings Per Share ¥ | ??? | ??? |
| ??? | ??? | |
| P/E | ??? | |
| EV/Sales | ??? |
10 Analysts have issued a Santen Pharmaceutical forecast for earnings per share. The average Santen Pharmaceutical EPS is
. This is than earnings per share in the financial year 2026. The highest EPS forecast is , the lowest is .This results in the following potential growth metrics and future valuations:
Santen Pharmaceutical...
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
